Download PDF
Planta Med 2002; 68(12): 1128-1131
DOI: 10.1055/s-2002-36355
Letter
© Georg Thieme Verlag Stuttgart · New York

Diayangambin Exerts Immunosuppressive and Anti-Inflammatory Effects in vitro and in vivo

Elvira J. De León1 , Dionisio A. Olmedo1 , Pablo N. Solís1 , Mahabir P. Gupta1 , M. Carmen Terencio2
  • 1Centro de Investigaciones Farmacognósticas de la Flora Panameña (CIFLORPAN), Facultad de Farmacia, Universidad de Panamá, Panamá
  • 2Departamento de Farmacología, Facultad de Farmacia, Universidad de Valencia, España
Further Information

Publication History

Received: April 17, 2002

Accepted: July 31, 2002

Publication Date:
20 December 2002 (online)

    Permissions and Reprints

Abstract

In this study, the furofuran lignan (+)-diayangambin [tetrahydro-1,4-bis(3,4,5-trimethoxyphenyl)-(1R)-1α,3aβ,4α,6aβ-1H,3H-furo [3,4-c]furan] was evaluated in vitro and in vivo for its immunomodulatory and anti-inflammatory efficacy. Human mononuclear cell proliferation was inhibited by diayangambin with an IC50 value of 1.5 (0.5 - 2.8) μM. In addition, the compound reduced for 40.8 % prostaglandin E2 generation in stimulated RAW 264.7 macrophage cell line at 10 μM. In vivo, a clear reduction of ear swelling was observed when diayangambin (40 mg/kg) was administered orally to 2,4-dinitrofluorobenzene-treated mice. The inhibition of swelling was associated with a reduction of leukocyte infiltration determined as myeloperoxidase activity. In the carrageenan mouse paw edema model, diayangambin significantly suppressed inflamed paw volume and prostaglandin E2 levels. Our findings indicate the potential interest of diayangambin in the treatment of immune and inflammatory responses.

References

  • 1 Pimentel-Muiños F X, Muñoz-Fernández  M A, Fresno M. Control of T lymphocyte activation and IL-2 receptor expression by endogenously secreted lymphokines.  J Immunol. 1994;  152 5714-22
    PubMedGoogle Scholar
  • 2 Vane J R, Mitchell J A, Appleton I, Tomlison A, Bishop-Bailey D, Croxtall J. et al . Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation.  Proc Natl Acad Sci USA. 1994;  91 2046-50
    PubMedGoogle Scholar
  • 3 MacRae W D, Towers G HN. Biological activities of lignans.  Phytochemistry. 1984;  23 1207-10
    CrossrefPubMedGoogle Scholar
  • 4 Cho J Y, Park J, Kim P S, Yoo E S, Baik K U, Park M H. Savinin, a lignan from Pterocarpus santalinus inhibits tumor necrosis factor-alpha production and T cell proliferation.  Biol Pharm Bull. 2001;  24 167-71
    CrossrefPubMedGoogle Scholar
  • 5 Cho J Y, Park J, Yoo E S, Yoshikawa K, Baik K U, Lee J. et al . Inhibitory effect of lignans from the rhizomes of Coptis japonica var. dissecta on tumor necrosis factor-alpha production in lipopolysaccharide-stimulated RAW 264.7 cells.  Arch Pharm Res. 1998;  21 12-6
    PubMedGoogle Scholar
  • 6 Serra M F, Díaz B, Barreto E O, Pereira A PB, Lima M CR, Barbosa-Filho J M. et al . Anti-allergic properties of the natural PAF antagonist yangambin.  Planta Med. 1997;  63 207-12
    Article in Thieme ConnectPubMedGoogle Scholar
  • 7 Prieto J M, Recio M C, Giner R , Mañez S, Massmanian A, Waterman P G. et al . Topical anti-inflammatory lignans from Haplophyllum hispanicum .  Z Naturforsch. 1996;  51 618-22
    PubMedGoogle Scholar
  • 8 Olmedo D A, Nakamura N, Hattori M, Correa M D, Solis P N, Gupta M P. Lignanos anti-Aedes aegypti de Piper fimbriulatum C.D. IV Simposio Internacional sobre Química de Productos Naturales y sus Aplicaciones. Chile; 1998 : 1 - 4 de Diciembre
    Google Scholar
  • 9 Gupta M P, Correa M D, Solís P, Jones A, Galdames C, Guionneau-Sinclair F. Medicinal plant inventory of Kuna Indians: Part 1.  J Ethnopharmacol. 1993;  40 77-9
    CrossrefPubMedGoogle Scholar
  • 10 De las Heras B, Slowing K, Benedi J, Carretero E, Ortega T, Toledo C. et al . Antiinflammatory and antioxidant activity of plants used in traditional medicine in Ecuador.  J Ethnopharmacol. 1998;  61 161-6
    CrossrefPubMedGoogle Scholar
  • 11 Freixa B, Vila R, Ferro E A, Adzet T, Cañigueral S. Antifungal principles from Piper fulvescens .  Planta Med. 2001;  67 873-5
    Article in Thieme ConnectPubMedGoogle Scholar
  • 12 Wang B, Fujisawa H, Zhuang L, Freed I, Howell B G, Shahid S. et al . CD4(+) Th1 and CD8(+) type 1 cytotoxic T cells both play a crucial role in the full development of contact hypersensitivity.  J Immunol. 2000;  165 6783-90
    PubMedGoogle Scholar
  • 13 Russell G B, Fenemore P Y. New lignans from leaves of Macropiper excelsum .  Phytochemistry. 1973;  12 1799-803
    CrossrefPubMedGoogle Scholar
  • 14 Rimando A M, Dayan F E, Mikell J R, Moraes R M. Phytotoxic lignans of Leucophyllum frutescens .  Nat Toxins. 1999;  7 39-43
    CrossrefPubMedGoogle Scholar
  • 15 Boyum A. Isolation of lymphocytes, granulocytes and macrophages.  Scand J Immunol Suppl. 1976;  5 9-15
    PubMedGoogle Scholar
  • 16 Babson A L, Phillips G E. A rapid colorimetric assay for serum lactic dehydrogenase.  Clin Chim Acta. 1965;  12 210-5
    CrossrefPubMedGoogle Scholar
  • 17 Borenfreund E, Babick H, Martin-Alguacil N. Comparison of two in vitro cytotoxicity assays.  The neutral red (NR) and tetrazolium (MTT) test Toxic In Vitro. 1968;  2 1-6
    PubMedGoogle Scholar
  • 18 Suzuki K, Ota H, Sasagawa S, Sakatani T, Fujikura T. Assay method for myeloperoxidase in human polymorphonuclear leukocytes.  Anal Biochem. 1983;  132 345-52
    CrossrefPubMedGoogle Scholar
  • 19 Moroney M A, Alcaraz M J, Forder R A, Carey F, Hoult J RS. Selectivity of neutrophil 5-lipoxygenase and cyclo-oxygenase inhibition by an anti-inflammatory flavonoid glycoside and related aglycone flavonoids.  J Pharm Pharmacol. 1978;  40 787-82
    PubMedGoogle Scholar

Dr. M. Carmen Terencio Silvestre

Departamento de Farmacología

Universidad de Valencia

Facultad de Farmacia

Avda. Vicent Andrés Estellés s/n

46100 Burjassot. Valencia

Spain

Email: Carmen.Terencio@uv.es

Fax: +34-96-3864943

      >